Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis

Clinical trial NCT00449748 · COMPLETED

Trial details

NCT number: NCT00449748
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Mastocytosis

Start date: 2007-04-01
Primary completion: 2009-10-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.